CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: In contrast, LSCs in CP-CML arise from cells with high inherent self-renewal, such as CD34+ CD38− HSCs, as the driver mutation (BCR–ABL1) impairs self-renewal [70].